First Hawaiian Bank Ironwood Pharmaceuticals Inc Transaction History

First Hawaiian Bank

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 12, 2022	SELL	$10.86 - $13.95 $5,484 - $7,044	-505 Reduced 1.43%	34,730 $405,000
Q3 2021 Oct 12, 2021	BUY	$11.92 - $13.92 $6,019 - $7,029	505 Added 1.45%	35,235 $460,000
Q4 2020 Jan 12, 2021	BUY	$9.05 - $12.2 $314,306 - $423,706	34,730 New	34,730 $396,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $530M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

Stay updated on First Hawaiian Bank with notifications on news.